Our Research Methodology
Our investigation began with a complete review of service offerings and pricing. We validated the medication tiers presented across Fridays’ public pages: compounded semaglutide at $249 month‑to‑month and as low as $150 on an annual prepay, and compounded tirzepatide at $359 down to $240 with extended commitments. Branded Wegovy and Ozempic pricing appears as a separate, high‑cost cash‑pay track unless insurance succeeds. We also confirmed that plan benefits explicitly include unlimited provider visits, group coaching, and insurance assistance, supporting the program’s “one price” framing at the plan level.
Testing their onboarding process revealed time‑boxed steps and standard logistics. Fridays’ own journey guidance sets expectations of provider processing in roughly 24 to 48 hours, with first‑time shipments arriving in 7 to 10 business days. Subsequent refills typically land in 5 to 7 business days after approval, with monthly shipping to respect beyond‑use dating. Tracking is provided via national carriers and mirrored in the patient portal. We verified that initial care commonly includes lab work, which their public journey timeline highlights in Month 1.
Our evaluation of account mechanics focused on billing, refills, and cancellations. Fridays documents that subscription charges occur every 28 days to maintain access, but refill shipments are not automated and must be requested each cycle. Cancellations must be sent to the dedicated email at least 72 hours before renewal; the current period remains non‑refundable except where law requires. Prepaid plans allow early termination with a refund calculated by re‑rating used months at the standard 1‑month price. These rules explain why proactive refill requests and calendar reminders matter for uninterrupted therapy.
During our analysis of fulfillment sourcing, we noted Fridays lists multiple pharmacy partners in its terms, reflecting a multi‑pharmacy approach. This can improve availability and explains minor packaging differences across shipments. We also reviewed their Privacy Notice, which clarifies that diagnosis, telehealth, and payment occur on Healthcare Provider Sites operated by third parties, and that Fridays maintains a Consumer Health Data appendix. Their medication safety content repeatedly reminds patients that compounded products are not FDA‑approved and sets clear limitations of use.
